Recombinant Zoster Vaccine Not Associated with Risk of Incident Gout, Study Finds
Receipt of RZV was not associated with an increased risk of incident gout among more than 1,000 adults ≥ 65 years of age who received at least 1 dose of the 2-dose vaccine regimen.
Source: hcplive.com